Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates:: Correlation with results of NCCLS M27-A2 multicenter study

被引：11

作者：

Cantón, E

Pemán, J

Gobernado, M

Alvarez, E

Baquero, F

Cisterna, R

Gil, J

Martín-Mazuelos, E

Rubio, C

Sánchez-Sousa, A

Serrano, C

机构：

[1] Hosp Univ Fe, Ctr Invest, Univ Microbiol Expt, Valencia 46009, Spain

[2] Hosp Univ Fe, Microbiol Serv, Valencia 46009, Spain

[3] Hosp Univ Ramon & Cajal, Madrid, Spain

[4] Hosp Univ Basurto, Bilbao, Spain

[5] Univ Lozano Blesa, Hosp Clin, Zaragoza, Spain

[6] Hosp Univ Valme, Seville, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 04期

关键词：

D O I：

10.1128/AAC.49.4.1604-1607.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The ability of Sensititre YeastOne to discriminate isolates with reduced caspofungin susceptibility was determined against 36 Candida spp. (6 with a known FKS1 mutation). Results were compared with those of M27-A2. The MIC endpoint was 100% growth inhibition. Overall agreement (+/- 2 log(2)) was 87.16%. Sensititre YeastOne detected strains with reduced caspofungin susceptibility.

引用

页码：1604 / 1607

页数：4